Laboratory Capacity Building & Diagnostic Support

The contract aims to strengthen laboratory capacity for the identification of fungal pathogens and the detection of antimicrobial resistance through infrastructure enhancement, personnel training, supply of essential reagents, and implementation of robust quality assurance protocols. This initiative is designed to improve diagnostic accuracy and response capabilities in clinical and public health settings by equipping laboratories with the tools and expertise needed to handle complex fungal samples and resistances that pose growing health threats. The scope encompasses technical upgrades to laboratory systems, ongoing staff development, and systematic monitoring to ensure consistent and reliable testing outcomes. Funded under the Centers for Disease Control and Prevention’s National Center for Emerging and Zoonotic Infectious Diseases, this subcontract falls under NAICS code 541380 and is structured to support long-term enhancements in infectious disease diagnostics. The opportunity was posted on July 30, 2026, with a response deadline of August 31, 2026, and is open to entities capable of delivering comprehensive laboratory support services without geographic restrictions specified. While the place of performance and point of contact details are not provided, the focus remains on scalable and sustainable improvements to national diagnostic readiness for fungal infections and resistance patterns.